After what time interval are we justified to diagnose immune checkpoint inhibitor-mediated polymyalgia rheumatica?
Dear Editor, the number of cases of cancer patients diagnosed as having immune checkpoint inhibitor-mediated polymyalgia rheumatica has been steadily rising in published reports. However, the lack of a validated scale or algorithm is still a relevant methodological limit in diagnosing this nosologi...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
PAGEPress Publications
2025-03-01
|
| Col·lecció: | Reumatismo |
| Matèries: | |
| Accés en línia: | https://www.reumatismo.org/reuma/article/view/1823 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|